Valuation: Waldencast plc

Market Cap 135M 117M 111M 101M 189M 12.91B 190M 1.32B 512M 6.56B 506M 495M 21B P/E 2026 *
-1.63x
P/E 2027 * -1.74x
Enterprise Value 135M 117M 111M 101M 189M 12.91B 190M 1.32B 512M 6.56B 506M 495M 21B EV / Sales 2026 *
0.47x
EV / Sales 2027 * 0.42x
Free-Float
46%
Yield 2026 *
-
Yield 2027 * -
09-14 Top Premarket Decliners MT
09-14 Waldencast Plans Voluntary Nasdaq Delisting; Shares Down Pre-Bell MT
07-29 Bridgepoint Europe VII and Bridgepoint Europe VII 2 LP, funds managed by Bridgepoint Advisers Limited, and Gore Range Capital Fund III Llc, a fund managed by Gore Range Capital LLC, acquired Obagi Cosmeceuticals LLC, Obagi Netherlands B.V. and Obagi AsiaPac Limited from Waldencast plc. CI
06-15 Waldencast plc Announces Fda Approval of Obagi Saypha Chiq Injectable Hyaluronic Acid Gel CI
06-15 Waldencast Says US FDA Approves Obagi Saypha ChIQ Injectable Hyaluronic Acid Gel MT
06-01 Waldencast plc Announces CEO Changes CI
06-01 Waldencast plc Announces Board Changes, Effective June 1, 2026 CI
06-01 Waldencast announces sale of Obagi Medical to Bridgepoint RE
05-31 Bridgepoint Europe VII and Bridgepoint Europe VII 2 LP, funds managed by Bridgepoint Advisers Limited, and Gore Range Capital Fund III Llc, a fund managed by Gore Range Capital LLC, entered into a definitive agreement to acquire Obagi Cosmeceuticals LLC, Obagi Netherlands B.V. and Obagi AsiaPac Limited from Waldencast plc for $460 million. CI
05-15 Obagi Medical Shares New Data on Recent Innovations At Music City Symposium for Cosmetic Advances and Laser Education Meeting CI
05-14 Obagi Medical And Next Health Form Strategic Alliance To Launch The Skin Recharge Station Pop-Up Experience CI
04-30 Obagi Medical Launches Sun Shield Mineral Uv Barrier Protect Broad Spectrum Spf 40 for Distribution CI
04-29 Top Premarket Gainers MT
1 day+1.32%
1 week-14.29%
Current month-17.99%
1 month-15.56%
3 months-34.48%
6 months-27.39%
Current year-39.36%
1 week 1.05
Extreme 1.05
1.36
1 month 1.05
Extreme 1.05
1.47
Current year 0.72
Extreme 0.72
2.01
1 year 0.72
Extreme 0.72
3.22
3 years 0.72
Extreme 0.72
12
5 years 0.72
Extreme 0.72
12.1
10 years 0.72
Extreme 0.72
12.1
Manager TitleAgeSince
Chief Executive Officer 60 2026-07-29
Investor Relations Contact - -
General Counsel - 2023-08-31
Director TitleAgeSince
Chairman 60 2020-12-31
Director/Board Member 60 2021-11-30
Director/Board Member 52 2021-02-28
Date Insider Type Main position Quantity % Market Cap. Importance
8/28/26
Zeno Equity Partners LLP
BuyCompany 335,000 0.2774%
7/30/26 Exercice

Chief Financial Officer

158,578 0.1313%
7/30/26 Issuer sale

Founder

-193,816 0.1605%
Change 5-day change 1-year change 3-year change Capi.($)
+1.32%-14.29%-35.96%-84.98% 135M
+0.07%-3.98%+29.78%+61.03% 32.96B
+2.99%+1.86%+3.17%+33.75% 22.68B
-0.47%-3.44%+17.08% - 11.01B
+2.48%-1.52%-33.21%-52.38% 3.37B
-1.36%-0.41%+61.33%+48.71% 2.47B
-1.48%-3.82%-38.57% - 922M
+0.19%+0.94%+34.17%+328.80% 573M
+12.00%+15.29% - - 500M
+3.57%+14.85%+84.13%0.00% 443M
Average +2.03%-3.24%+13.55%+47.85% 7.51B
Weighted average by Cap. +1.00%-3.70%+17.40%+46.26%

Financials

2026 *2027 *
Net sales 285M 249M 235M 214M 399M 27.33B 401M 2.8B 1.08B 13.89B 1.07B 1.05B 44.46B 318M 277M 262M 238M 445M 30.44B 447M 3.12B 1.21B 15.47B 1.19B 1.17B 49.53B
Net income -81.16M -70.69M -66.9M -60.78M -114M -7.77B -114M -797M -308M -3.95B -305M -298M -12.65B -76.15M -66.32M -62.77M -57.03M -107M -7.29B -107M -748M -289M -3.71B -286M -280M -11.86B
Net Debt - -
Logo Waldencast plc
Waldencast plc is a global multi-brand beauty and wellness platform. It is focused on developing, acquiring, accelerating, and scaling conscious and purpose-driven brands. Its segments include Obagi Medical and Milk Makeup. The Obagi Medical segment sells advanced skincare products backed by science and formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and to protect and enhance skin tone and texture. Its portfolio of medical-grade skincare with consumer-centric, in-office injectable procedures includes Saypha ChIQ, and MagIQ lines of injectable hyaluronic acid gels. The Milk Makeup segment consists of the business of Milk. Its Milk’s business activities include developing, marketing, and selling cosmetics, skincare, and other beauty products. Its Milk Makeup segment offers over 250 products through its United States Website www.MilkMakeup.com and retail partners include Sephora globally and Ulta Beauty in the United States.
Employees
367
Date Price Change Volume
26-09-15 US$1.140 +1.79% 287,403
26-09-15 US$1.120 -5.08% 151,179
26-09-14 US$1.180 -9.92% 2,751,775
26-09-11 US$1.310 -1.50% 39,045
26-09-10 US$1.330 0.00% 76,403
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.140USD
Average target price
2.367USD
Spread / Average Target
+107.60%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. WALD Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!